Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 487-496

  Hoffman, Alexander F ^a   Lupica, Carl R ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE TRANSPORTER; HALOTHANE; NOMIFENSINE; POTASSIUM CHLORIDE; SEROTONIN TRANSPORTER;

AMPEROMETRY; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ELECTROCHEMISTRY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOMIFENSINE; NOREPINEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SUBSTANTIA NIGRA;

EID: 0032465470     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Ann Rev Neurosci 16:73-93.
2. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
3. Cass WA and Gerhardt GA (1995) In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-207.
4. Cass WA, Gerhardt GA, Gillespie K, Curella P, Mayfield RD and Zahniser NR (1993a) Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J Neurochem 61:273-283.
5. Cass WA, Zahniser NR, Flach KA and Gerhardt GA (1993b) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61:2269-2278.
6. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB and Levey AI (1995) The dopamine transporter: Immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
7. 125I]RTI-55. Brain Res 690:217-224.
8. Cragg SJ, Hawkey CR and Greenfield SA (1997a) Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: Region and species differences. J Neurochem 69:2378-2386.
9. Cragg SJ, Rice ME and Greenfield SA (1997b) Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area and striatum. J Neurophysiol 77:863-873.
10. Elverfors A, Jonason J, Jonason G and Nissbrandt H (1997) Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from supervised substantia nigra slices. Synapse 26:359-369.
11. Eshleman AJ, Henningsen RA, Neve KA and Janowsky A (1994) Release of dopamine via the human transporter. Mol Pharmacol 45:312-316.
12. Friedemann MN and Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13:325-332.
13. 3H]nisoxetine binding in rat brain. J Neurochem 64: 2792-2800.
14. Gerhardt GA (1995) Rapid chronocoulometric measurements of norepinephrine overflow and clearance in CNS tissues. In: Neuromethods 27: Voltammetric Methods in Brain Systems (Boulton A, Baker G and Adams RN, eds) pp 117-151, Humana Press, Clifton, NJ.
15. Gerhardt GA, Gratton A and Rose GM (1988) In vivo electrochemical studies of the effects of cocaine on dopamine nerve terminals in the rat neostriatum. Physiol Bohemoslovaca 37:249-257.
16. Gerhardt GA and Palmer MR (1987) Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J Neurosci Methods 22:147-159.
17. Giros B and Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
18. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
19. Gratton A, Hoffer BJ and Gerhardt GA (1989) In vivo electrochemical studies of monoamine release in the medial prefrontal cortex of the rat. Neuroscience 29:57-64.
20. Graybiel AM (1995) The basal ganglia. Trends Neurosci 18:60-62.
21. Hausser M, Stuart G, Racca C and Sakmann B (1995) Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons. Neuron 15:637-647.
22. Hebert MA, van Horne CG, Hoffer BJ and Gerhardt GA (1996) Functional effects of GDNF in normal rat striatum: Presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther 279:1181-1190.
23. Heeringa MJ and Abercrombie ED (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release. J Neurochem 65:192-200.
24. Hoffman AF and Gerhardt GA (199B) In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J Neurochem 70:179-189.
25. Hoffman AF, van Horne CG, Eken S, Hoffer BJ and Gerhardt GA (1997) In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: Effects of unilateral 6-OHDA lesions and GDNF. Exp Neurol 147:130-141.
26. Hoffman BJ, Mezey E and Brownstein MJ (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254:579-580.
27. Hornykiewicz O and Kish SJ (1987) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45:19-34.
28. Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ and Gerhardt GA (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626:167-174.
29. Hyttel J (1982) Citalopram: Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharm Biol Psych 6:277-295.
30. Iravani MM and Kruk ZL (1997) Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25:93-102.
31. Kawagoe KT, Zimmerman JB and Wightman RM (1993) Principles of voltammetry and microelectrode surface states. J Neurosci Methods 48:225-240.
32. 3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. J Neurochem 45:137-144.
33. Luthman J, Friedemann MN, Hoffer BJ and Gerhardt GA (1997) In vivo electrochemical measurements of serotonin clearance in rat striatum: Effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors. J Neural Transm 104:379-397.
34. Nicholson C (1985) Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333:325-329.
35. Nirenberg MJ, Chan J, Liu Y, Edwards RH and Pickel VM (1996a) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine. J Neurosci 16:4135-4145.
36. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ and Pickel VM (1996b) The dopa-mine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447.
37. O'Connor JJ and Kruk ZL (1991) Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices. J Neurosci Methods 38:25-33.
38. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
39. Rice ME, Cragg SJ and Greenfield SA (1997) Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J Neurophysiol 77:853-862.
40. Rice ME, Richards CD, Nedergaard S, Hounsgaard J, Nicholson C and Greenfield SA (1994) Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res 100:395-406.
41. Richelson E and Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277-286.
42. Robertson GS and Robertson HA (1989) Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326-3331.
43. Simon JR and Ghetti B (1993) Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse. Neurochem Int 22:471-477.
44. Su MT, Dunwiddie TV and Gerhardt GA (1990) Combined electrochemical and electrophysiological studies of monoamine overflow in rat hippocampal slices. Brain Res 518:149-158.
45. Sulzer D, Maidment NT and Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527-535.
46. Tseng JL, Baetge EE, Zurn AD and Aebischer P (1997) GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci 17:325-333.